Following a national announcement, tirzepatide (Mounjaro®) will become available for weight management in primary care for some patients living with obesity. However, this does not mean the medication will be prescribed immediately to everyone who may be eligible. Access will be phased and guided by NHS eligibility criteria and local commissioning policies. Tirzepatide is intended to support weight loss alongside healthy lifestyle changes such as improved diet and increased physical activity. If you believe you may be eligible, please wait for further guidance from the practice. We will contact suitable patients when local prescribing pathways are confirmed. For more information please visit the links below Tirzepatide (Mounjaro) for weight management - Mid and South Essex Integrated Care System Weight management services - Mid and South Essex Integrated Care System